Streetbeat News

Stock Prices

SPIR

Spire Global (SPIR) is set to join the Russell 3000 Index, which could increase its visibility and attract more investors.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 10:50 am

WAY

Waystar Holding has launched its IPO, offering 45 million shares of common stock at an estimated price between $20.00 and $23.00 per share. The company has applied to list its shares on The Nasdaq Global Select Market under the symbol 'WAY' and plans to use the net proceeds to repay outstanding indebtedness.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 10:49 am

MRK

Merck's KEYTRUDA has shown a significant improvement in overall survival for patients with high-risk early-stage triple-negative breast cancer (TNBC) in the Phase 3 KEYNOTE-522 trial. The results will be presented at an upcoming medical meeting and shared with regulatory authorities.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 10:47 am

AY

Atlantica Sustainable Infrastructure (AY) has entered into a deal to be acquired by Energy Capital Partners and co-investors for $22 per share in cash, valuing the company at approximately $2.555 billion. The purchase price represents an 18.9% premium to Atlantica's closing share price on April 22, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 10:45 am

TSLA

Tesla Inc (NASDAQ:TSLA) employees in China have reportedly been registered for the FSD Beta program, indicating a potential step towards deploying Tesla's advanced driver assistance system in China. However, no FSD features have been activated yet. CEO Elon Musk aims to deploy FSD in all markets with regulatory approval, including China. Tesla shares closed up 3.2% at $179.24 on Monday but are down nearly 28% year to date.

Portfolio Pulse from Anan Ashraf

May 28, 2024 | 10:41 am

NVDA

SPY

USO

U.S. stock markets closed higher on Friday, driven by positive economic data and Nvidia's strong earnings. The Nasdaq marked its fifth consecutive weekly increase. In contrast, Asian and European markets dipped, while crude oil prices advanced towards $80 per barrel.

Portfolio Pulse from Akanksha Bakshi

May 28, 2024 | 10:40 am

GTHX

G1 Therapeutics, Inc. (NASDAQ:GTHX) announced positive Phase 2 clinical trial results showing improved overall survival (OS) and tolerability for patients receiving trilaciclib in combination with a TROP2 ADC (sacituzumab govitecan) compared to historical data from the ASCENT trial.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 10:35 am

INSM

Insmed announced that its Phase 3 study of Brensocatib achieved the primary endpoint for both dosage strengths, showing a statistically significant and clinically meaningful reduction in the frequency of pulmonary exacerbations compared to placebo. The study also met several secondary endpoints with statistical significance.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 10:33 am

ARCT

Arcturus Therapeutics (NASDAQ: ARCT) announced positive interim Phase 1b data for its cystic fibrosis treatment, ARCT-032. The data showed an average improvement of 4% FEV1 in the first four CF patients after two administrations. The company will present these findings at the European Cystic Fibrosis Conference on June 7, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 10:33 am

ELAN

Elanco announced that the FDA has completed its review of Bovaer, a first-in-class methane-reducing feed ingredient for the U.S. dairy industry. This development could have significant implications for the company's market position and environmental impact.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 10:29 am